References
- 1. A. V. Raveendran, E. C. Chacko and J. M. Pappachan, Non-pharmacological treatment options in the management of diabetes mellitus, Eur. Endocrinol. 14 (2018) 31–39; https://doi.org/10.17925/EE.2018.14.2.31
- 2. A. Hussain, O. B. Latiwesh, F. Ali, M. Y. G. Younis and J. A. Alammari, Effects of body mass index, glycemic control, and hypoglycemic drugs on serum uric acid levels in type 2 diabetic patients, Cureus 10 (2018) e3158; https://doi.org/10.7759/cureus.3158
- 3. G. T. Chen, B. B. Yang, J. H. Chen, Z. Zhang, L. L. Zhu, H. S. Jiang, W. Yu, Y. Chen and Y. T. Dai, Pancreatic kininogenase improves erectile function in streptozotocin-induced type 2 diabetic rats with erectile dysfunction, Asian J. Androl. 20 (2018) 448–453; https://doi.org/10.4103/aja.aja_23_18
- 4. L. Chen, S. E. Staubli, M. P. Schneider, A. G. Kessels, S. Ivic, L. M. Bachmann and T. M. Kessler, Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis, Eur. Urol. 68 (2015) 674–680; https://doi.org/10.1016/j.eururo.2015.03.031
- 5. R. S. Calabrò, G. Polimeni and P. Bramanti, Current and future therapies of erectile dysfunction in neurological disorders, Rec. Pat. CNS Drug Discov. 6 (2011) 48–64.
- 6. S. J. Flora, Role of free radicals and antioxidants in health and disease, Cell. Mol. Biol. 53 (2007) 1–2.
- 7. J. T. Coyle and P. Puttfarcken, Oxidative stress, glutamate, and neurodegenerative disorders, Science 262 (1993) 689–695.
- 8. M. C. Vogt and J. C. Brüning, CNS insulin signaling in the control of energy homeostasis and glucose metabolism – from embryo to old age, Trends Endocrinol. Metab. 24 (2013) 76–84; https://doi.org/10.1016/j.tem.2012.11.004
- 9. G. D. Calderon, N. Osnaya Brizuela, M. Ortiz Herrera, O. H. Juarez, A. Valenzuela Peraza and G. Barragan Mejía, Effect of an antiviral and vitamins A, C, D on dopamine and some oxidative stress markers in rat brain exposed to ozone, Arch. Biol. Sci. Belgrade 65 (2013) 1371–1379; https://doi.org/10.1186/s12868-018-0474-4
- 10. D. Calderón Guzmán, N. Osnaya Brizuela, M. Ortíz Herrera, E. Hernandez Garcia, G. Barragan Mejía, H. Juarez Olguín, A. Valenzuela Peraza, J. Attilus and N. Labra Ruiz, Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropionic acid, Acta Pharm. 66 (2016) 443–448; https://doi.org/10.1515/acph-2016-0027
- 11. F. Bilotta and G. Rosa, Optimal glycemic control in neurocritical care patients, Crit. Care 16 (2012) 163–165; https://doi.org/10.1186/cc11521
- 12. S. Ammon-Treiber, D. Stolze, H. Schroder, H. Loh and V. Hollt, Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model, Neuropharmacology 49 (2005) 1160–1169; https://doi.org/10.1016/j.neuropharm.2005.06.016
- 13. J. H. Jhamandas, K. H. Harris, T. Petrov and K. H. Jhamandas, Activation of nitric oxide-synthesizing neurons during precipitated morphine withdrawal, Neuroreport 7 (1996) 2843–2846.
- 14. G. D. Calderón, G. E. Hernández, M. G. Barragán, O. H. Juárez, G. J. Saldivar and R. N. Labra, Effect of morphine and lacosamide on levels of dopamine and 5-HIAA in brain regions of rats with induced hypoglycemia, Pak. J. Biol. Sci. 17 (2014) 292–296.
- 15. S. P. Filippov, ATPase activity of rat brain microsomal and synaptosomal fractions in insulin hypoglycemia and its treatment with glucose, Probl. Endokrinol. (Moskow) 37 (1991) 52–54; https://doi.org/10.1134/S0022093006020062
- 16. E. Mandosi, E. Giannetta, T. Filardi, M. Lococo, C. Bertolini, M. FAllarino, D. Gianfrilli, M. A. Venneri, L. Lenti, S. Morano and A. Lenzi, Endothelial dysfuntion markers as a therapeutic target for sildenafil treatment and effects on metabolic control in type 2 diabetes, Expert Opin. Ther. Target. 19 (2015) 1617–1622; https://doi.org/10.1517/14728222.2015.1066337
- 17. C. E. Ramirez, H. Nian, Y. Chang, L. J. Gamboa, J. M. Luther, N. J. Brown and C. A. Shibao, Treatment with sildenafil improves insulin sensitivity in prediabetes: a randomized, controlled trial, JCEM 100 (2015) 4533–4540; https://doi.org/10.1210/jc.2015-3415
- 18. F. G. Al-Amran, A. A. Zwain, N. R. Hadi and A. M. Al-Mudhaffer, Autonomic cerebral vascular response to sildenafil in diabetic patient, Diabetol. Metab. Syndr. 4 (2012) 2–8; https://doi.org/10.1186/1758-5996-4-2